CD37 immunotherapeutic combination therapies and uses thereof

• 收藏
• 分享

专利权人:

Emergent Product Development Seattle; LLC

发明人:

Cerveny, Charles G.,Thompson, Peter A.

申请号：

AU2013205305

公开号：

AU2013205305A1

申请日:

2013.04.18

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

#$%^&*AU2013205305A120130523.pdf#####The present disclosure provides methods for using CD37-specific binding molecules (such as a CD37-specific SMIP or antibody) in combination with mTOR inhibitors (such as rapamycin and derivatives or analogues thereof) or phosphatidylinositol 3-kinase (PI3K) inhibitors (such as p110-specific inhibitors or the like), which can be done concurrently or sequentially, to treat or prevent a B-cell related hyperproliferative disease, such as a lymphoma, carcinoma, myeloma, or the like.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/